BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.

Maintenance of genome integrity requires the functional interplay between Fanconi anemia (FA) and homologous recombination (HR) repair pathways. Endogenous acetaldehyde, a product of cellular metabolism, is a potent source of DNA damage, particularly toxic to cells and mice lacking the FA protein FA...

Full description

Bibliographic Details
Main Authors: Tacconi, E, Lai, X, Folio, C, Porru, M, Zonderland, G, Badie, S, Michl, J, Sechi, I, Rogier, M, Matía García, V, Batra, A, Rueda, O, Bouwman, P, Jonkers, J, Ryan, A, Reina-San-Martin, B, Hui, J, Tang, N, Bruna, A, Biroccio, A, Tarsounas, M
Format: Journal article
Language:English
Published: Wiley 2017
_version_ 1826303988998340608
author Tacconi, E
Lai, X
Folio, C
Porru, M
Zonderland, G
Badie, S
Michl, J
Sechi, I
Rogier, M
Matía García, V
Batra, A
Rueda, O
Bouwman, P
Jonkers, J
Ryan, A
Reina-San-Martin, B
Hui, J
Tang, N
Bruna, A
Biroccio, A
Tarsounas, M
author_facet Tacconi, E
Lai, X
Folio, C
Porru, M
Zonderland, G
Badie, S
Michl, J
Sechi, I
Rogier, M
Matía García, V
Batra, A
Rueda, O
Bouwman, P
Jonkers, J
Ryan, A
Reina-San-Martin, B
Hui, J
Tang, N
Bruna, A
Biroccio, A
Tarsounas, M
author_sort Tacconi, E
collection OXFORD
description Maintenance of genome integrity requires the functional interplay between Fanconi anemia (FA) and homologous recombination (HR) repair pathways. Endogenous acetaldehyde, a product of cellular metabolism, is a potent source of DNA damage, particularly toxic to cells and mice lacking the FA protein FANCD2. Here, we investigate whether HR-compromised cells are sensitive to acetaldehyde, similarly to FANCD2-deficient cells. We demonstrate that inactivation of HR factors BRCA1, BRCA2, or RAD51 hypersensitizes cells to acetaldehyde treatment, in spite of the FA pathway being functional. Aldehyde dehydrogenases (ALDHs) play key roles in endogenous acetaldehyde detoxification, and their chemical inhibition leads to cellular acetaldehyde accumulation. We find that disulfiram (Antabuse), an ALDH2 inhibitor in widespread clinical use for the treatment of alcoholism, selectively eliminates BRCA1/2-deficient cells. Consistently, Aldh2 gene inactivation suppresses proliferation of HR-deficient mouse embryonic fibroblasts (MEFs) and human fibroblasts. Hypersensitivity of cells lacking BRCA2 to acetaldehyde stems from accumulation of toxic replication-associated DNA damage, leading to checkpoint activation, G2/M arrest, and cell death. Acetaldehyde-arrested replication forks require BRCA2 and FANCD2 for protection against MRE11-dependent degradation. Importantly, acetaldehyde specifically inhibits in vivo the growth of BRCA1/2-deficient tumors and ex vivo in patient-derived tumor xenograft cells (PDTCs), including those that are resistant to poly (ADP-ribose) polymerase (PARP) inhibitors. The work presented here therefore identifies acetaldehyde metabolism as a potential therapeutic target for the selective elimination of BRCA1/2-deficient cells and tumors.
first_indexed 2024-03-07T06:11:03Z
format Journal article
id oxford-uuid:ef7f551b-08b6-4cc1-8592-354a32b1ae39
institution University of Oxford
language English
last_indexed 2024-03-07T06:11:03Z
publishDate 2017
publisher Wiley
record_format dspace
spelling oxford-uuid:ef7f551b-08b6-4cc1-8592-354a32b1ae392022-03-27T11:40:46ZBRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef7f551b-08b6-4cc1-8592-354a32b1ae39EnglishSymplectic Elements at OxfordWiley2017Tacconi, ELai, XFolio, CPorru, MZonderland, GBadie, SMichl, JSechi, IRogier, MMatía García, VBatra, ARueda, OBouwman, PJonkers, JRyan, AReina-San-Martin, BHui, JTang, NBruna, ABiroccio, ATarsounas, MMaintenance of genome integrity requires the functional interplay between Fanconi anemia (FA) and homologous recombination (HR) repair pathways. Endogenous acetaldehyde, a product of cellular metabolism, is a potent source of DNA damage, particularly toxic to cells and mice lacking the FA protein FANCD2. Here, we investigate whether HR-compromised cells are sensitive to acetaldehyde, similarly to FANCD2-deficient cells. We demonstrate that inactivation of HR factors BRCA1, BRCA2, or RAD51 hypersensitizes cells to acetaldehyde treatment, in spite of the FA pathway being functional. Aldehyde dehydrogenases (ALDHs) play key roles in endogenous acetaldehyde detoxification, and their chemical inhibition leads to cellular acetaldehyde accumulation. We find that disulfiram (Antabuse), an ALDH2 inhibitor in widespread clinical use for the treatment of alcoholism, selectively eliminates BRCA1/2-deficient cells. Consistently, Aldh2 gene inactivation suppresses proliferation of HR-deficient mouse embryonic fibroblasts (MEFs) and human fibroblasts. Hypersensitivity of cells lacking BRCA2 to acetaldehyde stems from accumulation of toxic replication-associated DNA damage, leading to checkpoint activation, G2/M arrest, and cell death. Acetaldehyde-arrested replication forks require BRCA2 and FANCD2 for protection against MRE11-dependent degradation. Importantly, acetaldehyde specifically inhibits in vivo the growth of BRCA1/2-deficient tumors and ex vivo in patient-derived tumor xenograft cells (PDTCs), including those that are resistant to poly (ADP-ribose) polymerase (PARP) inhibitors. The work presented here therefore identifies acetaldehyde metabolism as a potential therapeutic target for the selective elimination of BRCA1/2-deficient cells and tumors.
spellingShingle Tacconi, E
Lai, X
Folio, C
Porru, M
Zonderland, G
Badie, S
Michl, J
Sechi, I
Rogier, M
Matía García, V
Batra, A
Rueda, O
Bouwman, P
Jonkers, J
Ryan, A
Reina-San-Martin, B
Hui, J
Tang, N
Bruna, A
Biroccio, A
Tarsounas, M
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title_full BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title_fullStr BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title_full_unstemmed BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title_short BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
title_sort brca1 and brca2 tumor suppressors protect against endogenous acetaldehyde toxicity
work_keys_str_mv AT tacconie brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT laix brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT folioc brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT porrum brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT zonderlandg brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT badies brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT michlj brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT sechii brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT rogierm brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT matiagarciav brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT batraa brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT ruedao brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT bouwmanp brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT jonkersj brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT ryana brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT reinasanmartinb brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT huij brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT tangn brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT brunaa brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT biroccioa brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity
AT tarsounasm brca1andbrca2tumorsuppressorsprotectagainstendogenousacetaldehydetoxicity